News

Such a change would put the U.S. more in line with guidance in other countries and with the World Health Organization, which ...
Dr. Ali Sherif normally gives about 50 doses of the measles vaccine to children each month at his clinic in Hobbs, New Mexico ...
Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.
Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...
There are two vaccines approved by the FDA -- RotaTeq and Rotarix -- that protect against rotavirus, the most common cause of ...
Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...
Major drug companies are beginning to deliver their first-quarter readouts to Wall Street analysts, revealing their ...
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...
Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...
Health-care companies rose as earnings continued to come in strong. AbbVie shares rose after the drugmaker posted earnings ahead of Wall Street targets.
Selling, general and administrative expenses were $2.6 billion in the first quarter, Merck noted, an increase of 3% compared with the first quarter of 2024. The increase was primarily due to higher ...